COVID-19 Test Project with NGen and Response Biomedical

COVID-19 test development with Ngen and Response Biomedical

Response Biomedical is excited to be a part of Next Generation Manufacturing Canada’s (NGen) fight against COVID-19 by developing a 15 minute COVID-19 test on the RAMP® platform. The RAMP platform technology is a fluorescent-based lateral-flow immunoassay Point of Care (POC) system with Health Canada clearance, proudly manufactured and developed in Vancouver, BC.

We have developed tests for cardiovascular biomarkers such as: D-dimer, Troponin, Procalcitonin, and NT-proBNP, as well as for infectious diseases such as: influenza and respiratory syncytial virus (RSV) for people around the globe. Our goal is to provide a rapid, economical, and accurate COVID-19 diagnostic test for use in point-of-care settings near patients or in your community.

With the support of NGen, we aim to develop and manufacture, at large scale, a RAMP point-of-care test that detects SARS-CoV-2 in 15 minutes or less in patients presenting with symptoms of COVID-19.

Read more about the NGen project and other great Canadian manufacturers taking on the fight against COVID-19 below.

https://markets.businessinsider.com/news/stocks/advanced-manufacturing-supercluster-launches-innovative-solutions-to-fight-covid-19-1029157770

Share:

More News

covid-19 antibody test serology

COVID-19 Antibody Test Development

Response Biomedical Corp. is proud to be part of Canada’s fight against COVID-19 by developing a COVID-19 Antibody (Serology) test on the RAMP® platform. The

24 Hour Technical Support Available for all RAMP Customers

Contact Our Specialists

To See How We can Help You

QUICK QUOTE

Share on linkedin
Share on facebook
Share on google
Share on twitter
Share on email

Share this page

Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email